The global orthobiologics industry, valued at USD 6.0 billion in 2023, is projected to grow at a steady compound annual growth rate (CAGR) of 3.0% during the forecast period, reaching USD 8.1 billion by 2033. This growth highlights the increasing adoption of orthobiologic products in treating musculoskeletal disorders and enhancing bone healing and regeneration. Orthobiologics, …
Continue reading “Orthobiologics Industry to Reach USD 8.1 Billion by 2033, Growing at a 3.0% CAGR”